Cargando…
Asthma in Menopausal Women: Clinical and Functional Particularities
BACKGROUND: Hormonal changes in women, especially at menopausal transition, may have significant consequences on respiratory function. This issue in asthmatic patients is more frequent, more severe, and less controlled after menopause. Tunisian data regarding this issue are limited; therefore, we as...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Research Institute of Tuberculosis and Lung Disease
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008417/ https://www.ncbi.nlm.nih.gov/pubmed/33815542 |
_version_ | 1783672691116474368 |
---|---|
author | Zaibi, Haifa Touil, Amany Fessi, Rana Ben Amar, Jihen Aouina, Hichem |
author_facet | Zaibi, Haifa Touil, Amany Fessi, Rana Ben Amar, Jihen Aouina, Hichem |
author_sort | Zaibi, Haifa |
collection | PubMed |
description | BACKGROUND: Hormonal changes in women, especially at menopausal transition, may have significant consequences on respiratory function. This issue in asthmatic patients is more frequent, more severe, and less controlled after menopause. Tunisian data regarding this issue are limited; therefore, we assessed the clinical and functional particularities of asthma at menopausal transition. MATERIALS AND METHODS: This descriptive-analytical study was performed for two years (2016–2017) on 82 asthmatic women followed up in the pulmonology department of Charles Nicolle hospital of Tunis. According to hormonal status, two groups were defined: G1 (menopausal patients) and G2 (non-menopausal patients). Asthma control and severity of asthma as well as other variables including gender, age, body mass index (BMI), comorbidities, allergenic status, spirometry results, health care use in the past 12 months, and prescribed medications were evaluated. RESULTS: The mean age of patients was 50 years and half of them (60%) were menopausal women. Allergy was the most common cause of asthma (82%). A mean of 2.3 exacerbations per patient was recorded. Asthma was well controlled in 58% of patients and was moderate to severe in 80% of them. Menopausal asthmatic women had more comorbidities (p=0.006), particularly arterial hypertension (p<0.0001). Atopy was more common in non-menopausal women and they were all allergic (p=0.01). Menopausal asthmatic patients had more airflow obstruction with lower forced expiratory volume 1 and forced vital capacity (p<0.0001). They also had more exacerbations (p<0.0001) with lower PaO2 (p=0.006). Univariate analysis showed that menopause was a predictive factor of severity (p=0.01) and bad control of asthma (p=0.03). Multivariate analysis confirmed that menopause was a predictor of severity (p=0.01; OR=5.02, IC [1.36–18.46]) but not control of asthma despite the tendency to significance (p=0.07). CONCLUSION: Our results confirm that menopause is a factor influencing the control and severity of asthma. |
format | Online Article Text |
id | pubmed-8008417 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | National Research Institute of Tuberculosis and Lung Disease |
record_format | MEDLINE/PubMed |
spelling | pubmed-80084172021-04-02 Asthma in Menopausal Women: Clinical and Functional Particularities Zaibi, Haifa Touil, Amany Fessi, Rana Ben Amar, Jihen Aouina, Hichem Tanaffos Original Article BACKGROUND: Hormonal changes in women, especially at menopausal transition, may have significant consequences on respiratory function. This issue in asthmatic patients is more frequent, more severe, and less controlled after menopause. Tunisian data regarding this issue are limited; therefore, we assessed the clinical and functional particularities of asthma at menopausal transition. MATERIALS AND METHODS: This descriptive-analytical study was performed for two years (2016–2017) on 82 asthmatic women followed up in the pulmonology department of Charles Nicolle hospital of Tunis. According to hormonal status, two groups were defined: G1 (menopausal patients) and G2 (non-menopausal patients). Asthma control and severity of asthma as well as other variables including gender, age, body mass index (BMI), comorbidities, allergenic status, spirometry results, health care use in the past 12 months, and prescribed medications were evaluated. RESULTS: The mean age of patients was 50 years and half of them (60%) were menopausal women. Allergy was the most common cause of asthma (82%). A mean of 2.3 exacerbations per patient was recorded. Asthma was well controlled in 58% of patients and was moderate to severe in 80% of them. Menopausal asthmatic women had more comorbidities (p=0.006), particularly arterial hypertension (p<0.0001). Atopy was more common in non-menopausal women and they were all allergic (p=0.01). Menopausal asthmatic patients had more airflow obstruction with lower forced expiratory volume 1 and forced vital capacity (p<0.0001). They also had more exacerbations (p<0.0001) with lower PaO2 (p=0.006). Univariate analysis showed that menopause was a predictive factor of severity (p=0.01) and bad control of asthma (p=0.03). Multivariate analysis confirmed that menopause was a predictor of severity (p=0.01; OR=5.02, IC [1.36–18.46]) but not control of asthma despite the tendency to significance (p=0.07). CONCLUSION: Our results confirm that menopause is a factor influencing the control and severity of asthma. National Research Institute of Tuberculosis and Lung Disease 2020-07 /pmc/articles/PMC8008417/ /pubmed/33815542 Text en Copyright© 2020 National Research Institute of Tuberculosis and Lung Disease This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Original Article Zaibi, Haifa Touil, Amany Fessi, Rana Ben Amar, Jihen Aouina, Hichem Asthma in Menopausal Women: Clinical and Functional Particularities |
title | Asthma in Menopausal Women: Clinical and Functional Particularities |
title_full | Asthma in Menopausal Women: Clinical and Functional Particularities |
title_fullStr | Asthma in Menopausal Women: Clinical and Functional Particularities |
title_full_unstemmed | Asthma in Menopausal Women: Clinical and Functional Particularities |
title_short | Asthma in Menopausal Women: Clinical and Functional Particularities |
title_sort | asthma in menopausal women: clinical and functional particularities |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008417/ https://www.ncbi.nlm.nih.gov/pubmed/33815542 |
work_keys_str_mv | AT zaibihaifa asthmainmenopausalwomenclinicalandfunctionalparticularities AT touilamany asthmainmenopausalwomenclinicalandfunctionalparticularities AT fessirana asthmainmenopausalwomenclinicalandfunctionalparticularities AT benamarjihen asthmainmenopausalwomenclinicalandfunctionalparticularities AT aouinahichem asthmainmenopausalwomenclinicalandfunctionalparticularities |